WGA in Platinum-refractory HNSCC Underwent Nivolumab
Condition(s):HNSCCLast Updated:April 25, 2019Recruiting
Hide Studies Not Open or Pending
Condition(s):HNSCCLast Updated:April 25, 2019Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:July 9, 2020Recruiting
Condition(s):Metastatic Pancreatic CancerLast Updated:November 2, 2020Recruiting
Condition(s):Recurrent and/or Metastatic Platinum-refractory SCCHNLast Updated:November 20, 2020Active, not recruiting
Condition(s):Oral Cavity Squamous Cell CarcinomaLast Updated:October 8, 2020Recruiting
Condition(s):Hematologic MalignanciesLast Updated:June 25, 2020Terminated
Condition(s):Hodgkin LymphomaLast Updated:November 17, 2020Recruiting
Condition(s):Kidney Cancer; Lung CancerLast Updated:November 12, 2019Completed
Condition(s):Castration-resistant Prostate Cancer; Metastatic Prostate Cancer; Prostate CancerLast Updated:November 3, 2020Active, not recruiting
Condition(s):Glioblastoma MultiformeLast Updated:April 11, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.